EA
Emerald Advisers Portfolio holdings
AUM
$2.73B
1-Year Return
54.29%
This Quarter Return
-2.67%
1 Year Return
+54.29%
3 Year Return
+280.05%
5 Year Return
+497.66%
10 Year Return
+2,067.91%
AUM
$2.06B
AUM Growth
-$221M
(-9.7%)
Cap. Flow
-$19M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
18.33%
Holding
249
New
38
Increased
87
Reduced
99
Closed
17
Top Buys
| 1 |
AAR Corp
AIR
|
$23.4M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$14.7M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$13.1M |
| 4 |
RadNet
RDNT
|
$12.5M |
| 5 |
Weatherford International
WFRD
|
$11.6M |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$32.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$27.5M |
| 3 |
Planet Fitness
PLNT
|
$27.5M |
| 4 |
Super Micro Computer
SMCI
|
$16.8M |
| 5 |
Petco
WOOF
|
$14.1M |
Sector Composition
| 1 | Healthcare | 27.32% |
| 2 | Industrials | 21.96% |
| 3 | Technology | 19.12% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HES
151
DELISTED
Hess
HES
| $836K | 0.04% |
5,467
-116
| -2% | -$17.7K |
|
152
Pinterest
PINS
$25.2B
| $836K | 0.04% |
+30,913
| New | +$836K |
|
|
SGEN
153
DELISTED
Seagen Inc. Common Stock
SGEN
| $819K | 0.04% |
3,859
+2,371
| +159% | +$503K |
|
154
LPL Financial
LPLA
$28.8B
| $794K | 0.04% |
+3,339
| New | +$794K |
|
155
Veeva Systems
VEEV
$44.3B
| $762K | 0.04% |
3,745
-78
| -2% | -$15.9K |
|
156
Abbott
ABT
$231B
| $736K | 0.04% |
7,598
| – | – |
|
157
Costco
COST
$424B
| $734K | 0.04% |
1,300
| – | – |
|
158
Halliburton
HAL
$19.2B
| $713K | 0.03% |
17,615
-4,773
| -21% | -$193K |
|
159
Teva Pharmaceuticals
TEVA
$21.2B
| $688K | 0.03% |
+67,452
| New | +$688K |
|
160
L3Harris
LHX
$51.1B
| $672K | 0.03% |
3,858
+407
| +12% | +$70.9K |
|
161
Trex
TREX
$6.68B
| $632K | 0.03% |
10,262
+173
| +2% | +$10.7K |
|
162
Keysight
KEYS
$28.7B
| $579K | 0.03% |
4,376
-93
| -2% | -$12.3K |
|
163
Envista
NVST
$3.45B
| $572K | 0.03% |
20,515
-453
| -2% | -$12.6K |
|
164
MSCI
MSCI
$43.1B
| $558K | 0.03% |
+1,088
| New | +$558K |
|
165
Regeneron Pharmaceuticals
REGN
$60.1B
| $557K | 0.03% |
677
+272
| +67% | +$224K |
|
166
Trade Desk
TTD
$25.4B
| $556K | 0.03% |
7,116
+2,063
| +41% | +$161K |
|
167
Charles Schwab
SCHW
$177B
| $546K | 0.03% |
9,941
-4,627
| -32% | -$254K |
|
168
Alnylam Pharmaceuticals
ALNY
$59.4B
| $535K | 0.03% |
3,019
-67
| -2% | -$11.9K |
|
169
Amphenol
APH
$138B
| $530K | 0.03% |
12,618
-276
| -2% | -$11.6K |
|
170
New Fortress Energy
NFE
$644M
| $501K | 0.02% |
15,278
-336
| -2% | -$11K |
|
171
Mettler-Toledo International
MTD
$26.5B
| $475K | 0.02% |
429
+213
| +99% | +$236K |
|
172
Trimble
TRMB
$19B
| $470K | 0.02% |
8,726
-188
| -2% | -$10.1K |
|
173
ResMed
RMD
$40.1B
| $466K | 0.02% |
3,151
+688
| +28% | +$102K |
|
174
TechnipFMC
FTI
$16.3B
| $439K | 0.02% |
21,587
-17,621
| -45% | -$358K |
|
175
Icon
ICLR
$13.7B
| $437K | 0.02% |
+1,776
| New | +$437K |
|